Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

MB O2

Class 5Status: Objected
Application Number5359176
Trademark Status
Objected
Trademark Class5
Application Date2022-03-07
Proprietor NameMAXBIEN PHARMA PRIVATE LIMITED
Appropriate OfficeCHENNAI
StateTELANGANA
Trademark TypeWORD
User Details15/02/2022
Agent NameRAMJI.G ADVOCATE[29213]
Agent AddressRAMJI.G, ADVOCATE, AP1400, 6TH SECTOR, 31ST STREET, K.K.NAGAR, CHENNAI-600 078
Goods And Services Details[CLASS : 5] PHARMACEUTICAL, DRUGS, INJECTABLES, MEDICINAL PREPARATIONS AND SUBSTANCES FOR MEDICAL USE, being in CLASS-5

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
MB O25Objected
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about MB O2.

What is the status of trademark application 5359176?
The current status of trademark application 5359176 for MB O2 is Objected.
What is the trademark class of MB O2?
MB O2 is registered under trademark class 5.
Who is the proprietor of MB O2?
The proprietor of MB O2 is MAXBIEN PHARMA PRIVATE LIMITED.
When was trademark application 5359176 filed?
Trademark application 5359176 for MB O2 was filed on 2022-03-07.